Clinical trial
A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have…
NCT00002300 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00002300 |
|---|---|
| Title | A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition |
| Official title | Phase II-III Randomized Double-Blind Study Comparing Megestrol Acetate at 100, 400, and 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anorexia, Cachexia, HIV Infections |
| Intervention type | Drug |
| Interventions | Megestrol acetate |
| First posted | Aug 31, 2001 |
| Last update posted | Oct 2, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: